# Evoleen

Evoleen is an Asset Manager based in Zurich, Switzerland.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Zurich, Switzerland
- **Region:** Europe
- **Address:** Dreikönigstr. 34, 8002 Zürich, Switzerland
- **Founded:** 2018
- **Assets under management:** Undisclosed
- **Website:** evoleen.com
- **LinkedIn:** https://www.linkedin.com/company/evoleen

## Regulatory record

- **Reports private funds:** No

## About

At Evoleen we are transforming healthcare. Do you want to seize the opportunity to create something great? So do we! Innovative Health solutions are the answer to rising costs, limited access to healthcare, the challenges of ageing and chronic diseases. Let’s unlock the potential of healthtech solutions. 0 mastered therapeutic areas More than 0 Pharma […]

## Sectors

- Digital Health
- Healthcare Services

## Offices

- Munich, Germany

## People

- Chris Gugl — CEO & Co-Founder
- Andreas L. Csonka — CFO & Chief Investment Officer
- Jean-Daniel Sieber — Co-Founder
- Christoph Schröter — COO & Co-Founder
- Till Gerken — CTO & Co-Founder

## Questions

### What is Evoleen's investment model?

Evoleen operates as a venture builder, not a conventional fund. It co-creates healthtech ventures with pharma and medtech partners under a fee-for-service and shared-risk model. The firm takes equity stakes in the companies it builds and provides end-to-end services from strategy through clinical validation and market deployment.

### Who leads investment and operational decisions at Evoleen?

CEO Chris Gugl drives the commercial and strategic direction, while CFO Andreas Csonka, who earlier worked in investment banking, oversees the firm's financial and investment structuring. The broader co-founder group — Christoph Schröter (COO) and Till Gerken (CTO) — controls regulatory and technical execution across portfolio ventures.

### Which healthcare sectors does Evoleen target?

Evoleen's work spans more than 12 therapeutic areas including digital health, smart medical devices (Class I to III), neuroscience and behavioral health. The firm has confirmed ventures in diabetes integrated care, medication adherence, and remote monitoring via spinouts such as SIVA, Collabree, and Carity.

### Does Evoleen have a presence beyond Switzerland?

Yes. In addition to its Zurich headquarters, Evoleen maintains an office in Munich, Germany. The firm is active with partners across Europe, the United States, Asia and the Middle East, and in 2023 signed a collaboration agreement with the Saudi Arabia Ministry of Health's Model of Care.

### How does Evoleen relate to Evoleen Access?

Evoleen Access is a distinct unit within the Evoleen group, led by founder Michael Gschwandtner. It focuses solely on helping healthcare companies bring products through regulatory and quality-management hurdles — particularly ISO 13485 certification — without the full venture-building engagement.

### Who are Evoleen's typical partners?

Since 2018 more than 30 pharma and medtech companies have partnered with Evoleen. The firm publicizes relationships with former executives from Sanofi, Eli Lilly, and Sonova/Phonak among its advisors. It also collaborates with public institutions, hospitals, and NGOs on health-solution pilots and scaled roll-outs.

## Related profiles

- [Evok Innovations](https://altss.com/profile/evok-innovations)
- [Evolute Capital](https://altss.com/profile/evolute-capital)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/evoleen

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology